![Michelle Rashford](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Michelle Rashford
Sociétés | Poste | Début | Fin |
---|---|---|---|
RACE ONCOLOGY LIMITED | Directeur Technique/Scientifique/R&D | 01/07/2023 | - |
Historique de carrière de Michelle Rashford
Anciens postes connus de Michelle Rashford
Sociétés | Poste | Début | Fin |
---|---|---|---|
Kyowa Kirin, Inc. | Directeur Technique/Scientifique/R&D | 01/07/2020 | 01/10/2022 |
Hangzhou Adlai Nortye Biopharma Co. Ltd.
![]() Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Directeur Technique/Scientifique/R&D | 01/09/2018 | 01/06/2020 |
Statistiques
Internationale
Australie | 2 |
Chine | 2 |
Etats-Unis | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
RACE ONCOLOGY LIMITED | Health Technology |
Entreprise privées | 2 |
---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
![]() Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Health Technology |
Kyowa Kirin, Inc. |
- Bourse
- Insiders
- Michelle Rashford
- Expérience